Susquehanna Fundamental Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-114,661
| Closed | -$15.7M | – | 1174 |
|
|
2024
Q4 | $15.7M | Buy |
+114,661
| New | +$15.7M | 0.22% | 109 |
|
|
2024
Q2 | $509K | Buy |
+3,695
| New | +$509K | 0.01% | 688 |
|
|
2021
Q4 | – | Sell |
-47,618
| Closed | -$4.57M | – | 1659 |
|
|
2021
Q3 | $4.57M | Buy |
47,618
+40,168
| +539% | +$3.85M | 0.08% | 317 |
|
|
2021
Q2 | $725K | Sell |
7,450
-13,966
| -65% | -$1.36M | 0.01% | 1006 |
|
|
2021
Q1 | $2.08M | Sell |
21,416
-396
| -2% | -$38.5K | 0.04% | 630 |
|
|
2020
Q4 | $2.09M | Buy |
+21,812
| New | +$2.09M | 0.04% | 607 |
|